The cardioprotective role of NACA in the prevention of Doxorubicin and Trastuzumab mediated cardiac dysfunction

was 149.7(13.6)/83.4(11.5) mm Hg at baseline. The intervention group had an adjusted mean (SE) reduction in systolic BP at 6 months of 18.0 (1.4) mm Hg compared with 11.0 (2.1) mm Hg in the control group (p1⁄40.005). CONCLUSION: Pharmacist prescribing for patients with uncontrolled hypertension resulted in a statistically and clinically significant reduction in systolic blood pressure when compared to usual care. CIHR, AIHS